World Top 100 Healthcare Companies List by Market Cap as of August 2026

World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.

World Top Healthcare Companies in 2026
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.

  1. Anhui Anke Biotechnology (Group)

    World Rank (Aug-2026)
    5,981
    Market Cap (Aug-2026)
    2.224 Billion USD
    World Rank (Jan-05-2024)
    5,081
    Market Cap (Jan-05-2024)
    2.400 Billion USD
    World Rank (Jul-30-2023)
    4,984
    Market Cap (Jul-30-2023)
    2.472 Billion USD
    World Rank (Dec-25-2022)
    4,882
    Market Cap (Dec-25-2022)
    2.345 Billion USD
    World Rank (Jan-07-2022)
    4,470
    Market Cap (Jan-07-2022)
    3.36 Billion USD
    Annual Revenue in USD
    315 Million USD
    Annual Net Income in USD
    30 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    ANHUI ANKE BIOTECHNOLOGY (GROUP)

  2. Harmony Biosciences Holdings Inc.

    World Rank (Aug-2026)
    5,989
    Market Cap (Aug-2026)
    2.220 Billion USD
    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    868 Million USD
    Annual Operating Income in USD
    208 Million USD
    Annual Net Income in USD
    159 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

    Company Website
    HARMONY BIOSCIENCES HOLDINGS, INC.

  3. Bellus Health

    World Rank (Aug-2026)
    5,990
    World Rank (Jan-05-2024)
    5,990
    World Rank (Jul-30-2023)
    5,990
    Market Cap (Jul-30-2023)
    1.870 Billion USD
    World Rank (Dec-25-2022)
    7,834
    Market Cap (Dec-25-2022)
    1.121 Billion USD
    World Rank (Jan-07-2022)
    11,402
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Headquarters Country
    Canada
    Company Profile

    BELLUS Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders. Headquarters is in Canada.

    Company Website
    BELLUS HEALTH

  4. Biohaven Pharmaceutical Holding Company

    World Rank (Aug-2026)
    6,000
    Market Cap (Aug-2026)
    2.211 Billion USD
    World Rank (Jan-05-2024)
    3,972
    Market Cap (Jan-05-2024)
    3.399 Billion USD
    World Rank (Jul-30-2023)
    7,470
    Market Cap (Jul-30-2023)
    1.300 Billion USD
    World Rank (Dec-25-2022)
    8,706
    Market Cap (Dec-25-2022)
    0.934 Billion USD
    World Rank (Jan-07-2022)
    2,147
    Market Cap (Jan-07-2022)
    8.44 Billion USD
    Annual Revenue in USD
    463 Million USD
    Annual Operating Income in USD
    -704 Million USD
    Annual Net Income in USD
    -847 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile

    Biohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.

    Company Website
    BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

  5. Zhejiang Jiuzhou Pharmaceutical Co. Ltd

    World Rank (Aug-2026)
    6,008
    Market Cap (Aug-2026)
    2.208 Billion USD
    World Rank (Jan-05-2024)
    4,571
    Market Cap (Jan-05-2024)
    2.829 Billion USD
    World Rank (Jul-30-2023)
    4,094
    Market Cap (Jul-30-2023)
    3.276 Billion USD
    World Rank (Dec-25-2022)
    2,941
    Market Cap (Dec-25-2022)
    4.584 Billion USD
    World Rank (Jan-07-2022)
    2,722
    Market Cap (Jan-07-2022)
    6.31 Billion USD
    Annual Revenue in USD
    591 Million USD
    Annual Net Income in USD
    92 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shanghai
    Company Profile
    Zhejiang Jiuzhou Pharmaceutical Co. Ltd is committed to the research and development, production and sale of active pharmaceutical ingredients company. It has undertaken more than 30 national and provincial research projects. The company annual revenue is 306 million USD and 2,998 employees as on 2019. The headquarters is in China.
    Company Website
    ZHEJIANG JIUZHOU PHARMACEUTICAL CO. LTD

  6. Ocular Therapeutix

    World Rank (Aug-2026)
    6,015
    Market Cap (Aug-2026)
    2.205 Billion USD
    World Rank (Jan-05-2024)
    12,314
    Market Cap (Jan-05-2024)
    0.523 Billion USD
    World Rank (Jul-30-2023)
    14,969
    Market Cap (Jul-30-2023)
    0.350 Billion USD
    World Rank (Dec-25-2022)
    17,875
    Market Cap (Dec-25-2022)
    0.206 Billion USD
    World Rank (Jan-07-2022)
    13,549
    Market Cap (Jan-07-2022)
    0.49 Billion USD
    Annual Revenue in USD
    52 Million USD
    Annual Operating Income in USD
    -270 Million USD
    Annual Net Income in USD
    -266 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Ocular Therapeutix is a Biopharmaceutical Platform company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel based formulation technology. The company annual revenue is 12.3 million USD and 167 employees as on 2019. The headquarters is in USA.
    Company Website
    OCULAR THERAPEUTIX

  7. Nuvation Bio Inc.

    World Rank (Aug-2026)
    6,043
    Market Cap (Aug-2026)
    2.184 Billion USD
    World Rank (Jan-05-2024)
    15,248
    Market Cap (Jan-05-2024)
    0.327 Billion USD
    World Rank (Jul-30-2023)
    14,372
    Market Cap (Jul-30-2023)
    0.385 Billion USD
    World Rank (Dec-25-2022)
    14,104
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    7,508
    Market Cap (Jan-07-2022)
    1.47 Billion USD
    Annual Revenue in USD
    63 Million USD
    Annual Operating Income in USD
    -213 Million USD
    Annual Net Income in USD
    -205 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile

    Nuvation Bio is a Biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. The headquarters is in USA.

    Company Website
    NUVATION BIO INC.

  8. Precigen Inc.

    World Rank (Aug-2026)
    6,044
    Market Cap (Aug-2026)
    2.184 Billion USD
    World Rank (Jan-05-2024)
    15,259
    Market Cap (Jan-05-2024)
    0.326 Billion USD
    World Rank (Jul-30-2023)
    15,121
    Market Cap (Jul-30-2023)
    0.341 Billion USD
    World Rank (Dec-25-2022)
    15,801
    Market Cap (Dec-25-2022)
    0.296 Billion USD
    World Rank (Jan-07-2022)
    11,639
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -111 Million USD
    Annual Net Income in USD
    -251 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders and infectious diseases. The company annual revenue is 103 million USD as on 2020. The headquarters is in USA.
    Company Website
    PRECIGEN, INC.

  9. Hanall Biopharma

    World Rank (Aug-2026)
    6,045
    Market Cap (Aug-2026)
    2.183 Billion USD
    World Rank (Jan-05-2024)
    6,572
    Market Cap (Jan-05-2024)
    1.580 Billion USD
    World Rank (Jul-30-2023)
    9,371
    Market Cap (Jul-30-2023)
    0.883 Billion USD
    World Rank (Dec-25-2022)
    10,789
    Market Cap (Dec-25-2022)
    0.651 Billion USD
    World Rank (Jan-07-2022)
    10,233
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    76 Million USD
    Annual Net Income in USD
    7 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    South Korea
    Yahoo @ SouthKorea
    Company Profile
    Pharmaceutical Company with headquarters is in Seoul, South Korea.
    Company Website
    HANALL BIOPHARMA

  10. Oxford Nanopore Technologies PLC

    World Rank (Aug-2026)
    6,046
    Market Cap (Aug-2026)
    2.183 Billion USD
    World Rank (Jan-05-2024)
    5,281
    Market Cap (Jan-05-2024)
    2.265 Billion USD
    World Rank (Jul-30-2023)
    4,591
    Market Cap (Jul-30-2023)
    2.794 Billion USD
    World Rank (Dec-25-2022)
    4,612
    Market Cap (Dec-25-2022)
    2.547 Billion USD
    World Rank (Jan-07-2022)
    2,286
    Market Cap (Jan-07-2022)
    7.85 Billion USD
    Annual Revenue in USD
    254 Million USD
    Annual Operating Income in USD
    -126 Million USD
    Annual Net Income in USD
    -117 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    UK
    Company Profile

    Oxford Nanopore Technologies is a disruptive, electronic, single-molecule sensing system based company including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The company annual revenue is 113.9 million EUR as on 2020. The headquarters is in UK.

    Company Website
    OXFORD NANOPORE TECHNOLOGIES PLC

Share